How to find a needle in a haystack: a systematic review on targeting KRAS wild-type pancreatic cancer
GastroenterologiaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Future oncology (London, England)
- Publicado em
- 5 jun 2024
- Citações
- 6
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
How to find a needle in a haystack: a systematic review on targeting KRAS wild-type pancreatic cancer
Antoine Mouawad, Sofia Habib, Marc Boutros, Fouad Attieh, Hampig Raphaël Kourie
Descritores MeSH
- Pancreatic Neoplasms
- Biomarkers, Tumor
- Proto-Oncogene Proteins p21(ras)
- Humans
- Mutation
- Molecular Targeted Therapy
Veja também
Estudos relacionados
- Efficacy and safety signals from early-phase studies of KRAS inhibition in pancreatic cancer
- Prognostic utility of preoperative and postoperative KRAS-mutated circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
- Prognostic role of cell-free DNA biomarkers in pancreatic adenocarcinoma: A systematic review and meta-analysis
- A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial